COPYRIGHT © DIGITAL JOURNAL INC. Sitemaps: XML / News. Digital Journal is not responsible for the content of external sites. Read more about our external linking
United States, Nevada, Las Vegas, DelveInsight’s “Obesity – Market Insight, Epidemiology and Market Forecast – 2032” report provides current treatment practices, emerging drugs, Obesity market share of the individual therapies, current and forecasted Obesity market size from 2019 to 2032 segmented by seven major markets. The report also offers current Obesity therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Obesity market.
Obesity Overview
Obesity is defined as an abnormal or excessive accumulation of fat or adipose tissue in the body that presents a risk to health. The body mass index (BMI) is used to define obesity, which is calculated as weight (kg)/height (m2). A person with a body mass index greater than or equal to 30 is considered obese. It is the second most common cause of preventable death, which has its association with the risk of development of inflammatory components, directly and indirectly, related to cardiovascular disease, diabetes mellitus, respiratory problems, psychological issues, hypertension, obstructive sleep apnea, cancer, and hyperlipidemia. It imposes a significant public health epidemic that has progressively worsened over the past semi-centennial. An increase in obesity has been observed in children as well as adults of both genders and is prevalent in both developed and developing countries.
Obesity Epidemiological Insights
In the year 2021, the total prevalent cases of obesity in adults (>19 years) were 182.22 Million (M) and in children (5–19 years) were 7.85 million in the 7MM which are expected to grow during the study period, i.e., 2019–2032.
Obesity Treatment Market
Losing weight through healthy eating, increasing physical activity, and making other lifestyle changes are all common therapies for obesity. Some people may benefit from weight-management programs in order to lose weight or avoid regaining it. Some obese persons are either unable to drop enough weight to enhance their health or are unable to maintain their weight loss. Other therapies, such as weight-loss drugs, gadgets, or bariatric surgery, may be considered in such circumstances.
Within the first 6 months of treatment, it is recommended to decrease 5–10% of the body weight. It can help reduce the risk of developing obesity-related health problems, and improve health conditions associated with obesity, such as high blood pressure and high cholesterol levels.
So obesity can be managed by reducing calories and adopting healthier eating habits, physical activity, and weight loss medications like orlistat and phentermine.
Discover more about Obesity treatment therapies in the pipeline @ Obesity Drugs
Leading Companies Working in the Obesity Market
To understand key companies related to the Obesity Market, get a snapshot of the Obesity Regulatory and Patent Analysis.
Scope of the Obesity Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Obesity Companies: Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis, CSPC Baike (Shandong) Biopharmaceutical, Jiangsu HengRui Medicine, Carmot Therapeutics, Pfizer, Sciwind Biosciences, Empros Pharma, and others
Therapeutic Assessment: Obesity current marketed and emerging therapies
Obesity Market Dynamics: Obesity market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Obesity Market Access and Reimbursement
Table of Contents
Leading Reports by DelveInsight:
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Us
Kritika Rehani
info@delveinsight.com
+1(919)321-6187